Form 4 for NUTX Nutex Health Inc.
Accepted 2022-08-02 00:00:00 ET · period of report 2022-06-20 · accession 0001062993-22-017072 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-02 | 2022-06-20 | NUTX | Waters John J | Dir | C - Cnv Deriv | $1.55 | +64.5K | 146.3K | +79% | +$100.0K |
| D | 2022-08-02 | 2022-06-20 | NUTX | Waters John J | Dir | C - Cnv Deriv | $100,000.00 | -100.0K | 0 | -100% | -$10.00B |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-20 | C | A | 64,516 | $1.55 | 146,262 | D | — | — | |
| 2 | Derivative | Convertible Promissory Note | 2022-06-20 | C | D | 100,000 | $100,000.00 | 0 | D | $1.55 · 2019-11-19 to 2022-07-31 | 64,516 Common Stock | (F1) Convertible Promissory Note originally issued on 11/19/2019 and amended by (i) Assignment and Consent Agreement and Amendment to Subscription Agreement, Convertible Debenture and Warrant dated 9/30/2020 and (ii) Second Amendment to Convertible Promissory Note dated 1/29/2021. |